Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Epix Pharmaceuticals (United States) | Researchclopedia

Back to institutions

Epix Pharmaceuticals (United States)

Lexington, Massachusettscompany

350

Works

49,134

Citations

118

h-index

Top Research Topics

Advanced MRI Techniques and Applications Lanthanide and Transition Metal Complexes Gastrointestinal motility and disorders

Top Researchers

Maurizio Fava Massachusetts General Hospital

1,222 works88,340 citationsh-index: 137

Recent Research

SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose optimization study for a single dose of <sup>153</sup> Sm-DOTMP to treat metastatic bone pain.

Ebrahim Delpassand,Julio A. Peguero,et al.

20260 citations

MRI in cancer diagnosis

Radiopharmaceutical Chemistry and Applications

Cardiac Imaging and Diagnostics

Prostate Cancer Treatment and Research

Computational Drug Discovery Methods

Medical Imaging Techniques and Applications

RNA Interference and Gene Delivery

Receptor Mechanisms and Signaling

Advanced biosensing and bioanalysis techniques

Herbert L. DuPont The University of Texas MD Anderson Cancer Center

830 works42,636 citationsh-index: 106

Warren J. Manning Beth Israel Deaconess Medical Center

796 works42,183 citationsh-index: 102

Ira M. Jacobson NYU Langone Health

590 works41,056 citationsh-index: 87

Ulrich Förstermann Johannes Gutenberg University Mainz

328 works39,697 citationsh-index: 94

Li Liu University of Science and Technology Liaoning

1,751 works39,226 citationsh-index: 85

Phase 3 study of <sup>68</sup> Ga-PSMA-11 PET combined with MRI for the detection of prostate cancer (BIPASS).

Clint D. Bahler,Jérémie Calais,et al.

20260 citations

Phase 1B/2 study of combination <sup>177</sup> Lu girentuximab plus cabozantinib and nivolumab in treatment-naïve patients with advanced clear cell RCC.

Eric Jonasch,E. Hasanov,et al.

20260 citations

Abstract PS1-12-12: Comparative transcriptomic and proteomic analysis of lasofoxifene and fulvestrant, in an ER-mutated metastatic breast cancer explant model, identifies potential molecular mechanisms underlying differential treatment efficacy

M. Laine,D. A. Tieri,et al.

20260 citations

Abstract PS5-07-30: Open-label, randomized, multicenter, phase 3, ELAINE 3 study of the efficacy and safety of lasofoxifene plus abemaciclib for treating ER+/HER2-, locally advanced or metastatic breast cancer with an ESR1 mutation

M. P. Goetz,S. A. Wander,et al.

20260 citations

The EAT–Lancet Commission: issues and responses

Francisco J Zagmutt,Jane G. Pouzou,et al.

20260 citations